Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Aceclidine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    LENZ Therapeutics Submits MAA to EMA for VIZZ in Presbyopia
    LENZ Therapeutics Submits MAA to EMA for VIZZ in Presbyopia

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252745/0/en/LENZ-Therapeutics-Announces-Submission-of-Marketing-Authorization-Application-to-European-Medicines-Agency-for-VIZZ-for-the-Treatment-of-Presbyopia.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    Lenz Therapeutics Launches Vizz In Us Market
    Lenz Therapeutics Launches Vizz In Us Market

    30 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lenz-therapeutics-announces-commercial-product-availability-of-vizz-in-the-united-states-302570157.html

    PR NEWSWIRE
    30 Sep 2025
    Share Share
    Lenz Therapeutics to Present at Investor and Medical Conferences
    Lenz Therapeutics to Present at Investor and Medical Conferences

    25 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/25/3138414/0/en/LENZ-Therapeutics-to-Present-at-Upcoming-Investor-and-Medical-Conferences.html

    GLOBENEWSWIRE
    25 Aug 2025
    Share Share
    LENZ Therapeutics Gets FDA Approval for Presbyopia Treatment VIZZ
    LENZ Therapeutics Gets FDA Approval for Presbyopia Treatment VIZZ

    31 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/31/3125400/0/en/LENZ-Therapeutics-Announces-US-FDA-Approval-of-VIZZ-for-the-Treatment-of-Presbyopia.html

    GLOBENEWSWIRE
    31 Jul 2025
    Share Share
    LENZ Therapeutics’s Vizz Receives Approval in US
    LENZ Therapeutics’s Vizz Receives Approval in US

    31 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218585

    FDA
    31 Jul 2025
    Share Share
    LENZ Therapeutics Submits NDA for LNZ100 to NMPA in China
    LENZ Therapeutics Submits NDA for LNZ100 to NMPA in China

    28 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/28/3122426/0/en/LENZ-Therapeutics-Announces-NMPA-Submission-of-New-Drug-Application-for-LNZ100-in-China-for-the-Treatment-of-Presbyopia.html

    GLOBENEWSWIRE
    28 Jul 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.